Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
keynote 522 | 1.76 | 1 | 498 | 53 | 11 |
keynote | 1.08 | 0.8 | 8998 | 5 | 7 |
522 | 1.13 | 0.4 | 9703 | 98 | 3 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
keynote 522 | 0.26 | 0.3 | 3451 | 47 |
keynote 522 regimen | 0.2 | 0.7 | 8498 | 79 |
keynote 522 trial | 0.22 | 0.7 | 8635 | 44 |
keynote 522 protocol | 0.3 | 0.9 | 5725 | 9 |
keynote 522 nejm | 2 | 0.5 | 368 | 2 |
keynote 522 schema | 1.22 | 0.7 | 9013 | 86 |
keynote 522 update | 0.01 | 0.7 | 3782 | 35 |
keynote 522 study | 1.71 | 0.9 | 6354 | 10 |
keynote 522 breast cancer | 0.4 | 0.8 | 4131 | 34 |
keynote 522 regimen schedule | 0.31 | 0.5 | 8921 | 17 |
keynote 522 pembrolizumab | 0.97 | 0.2 | 3488 | 81 |
keynote 522 clinical trial | 1.31 | 0.5 | 8058 | 54 |
keynote 522 trial design | 1.83 | 0.4 | 2678 | 6 |
keynote 522 overall survival | 1.88 | 0.6 | 9564 | 36 |
keynote 522 breast cancer trial | 0.82 | 0.5 | 7057 | 81 |
what is keynote 522 regimen | 0.23 | 0.1 | 9587 | 72 |